Precigen | 8-K: Current report
Mar 20 04:22
Precigen | 8-K: Current report
Feb 9 05:27
Precigen | 8-K: Current report
Jan 8 13:00
Precigen | S-3: Registration statement for specified transactions by certain issuers
Dec 29, 2023 13:00
Precigen | 8-K: Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
Nov 10, 2023 06:07
Precigen | 8-K: Precigen Reports Second Quarter and First Half 2023 Financial Results and Provides Update on Portfolio Prioritization and Capital Allocation Strategies to Extend Projected Cash Runway into 2025
Aug 9, 2023 20:15
Precigen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jul 7, 2023 05:09
Precigen | 8-K: Current report
Jun 10, 2023 04:32
Precigen | 8-K: Precigen Reports First Quarter 2023 Financial Results and Business Updates
May 10, 2023 20:00
Precigen | DEFA14A: Others
Apr 26, 2023 04:15
Precigen | DEF 14A: Definitive proxy statements
Apr 26, 2023 04:06
Precigen | 8-K: Current report
Apr 5, 2023 09:16
Precigen | 8-K: Current report
Mar 13, 2023 18:06
Precigen | 8-K: Precigen Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
Mar 7, 2023 05:13
Precigen | 8-K: Current report
Jan 27, 2023 21:31
Precigen | 8-K: Current report
Jan 25, 2023 05:10
Precigen | 8-K: Current report
Jan 12, 2023 08:01
Precigen | 8-K: Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs
Nov 10, 2022 05:14
Precigen: Current report
8-K | PRECIGEN, INC. (0001356090) (Filer)
Sep 22, 2022 05:07
Precigen | 8-K/A: Current report (Amendment)
Aug 25, 2022 04:28
No Data
No Data